跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Axalav 457 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Axalav 457
Approved
STANDARD
Axalav 457
Uni Medicolabs
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ef17437cbdf23355
Company
Uni Medicolabs
Type
Standard
Approval Details
Approval Id
ef17437cbdf23355
Drug Approval Philippines Name
Axalav 457
Product Name
Axalav 457
Registration Number
DRP-16384
Brand Name
Axalav 457
Generic Name
Co-Amoxiclav
Dosage Form
Powder for Oral Suspension
Dosage Strength
457 mg/5 mL
Manufacturer
Uni Medicolabs
Issuance Date
28 February 2025
Expiry Date
28 February 2030
Pharmacologic Category
Antibacterial (Penicillins)
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ef17437cbdf23355
Type
Standard
Back to Philippines FDA Approvals